nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—germ cell cancer—head and neck cancer	0.434	1	CtDrD
Vinblastine—TUBB2B—Docetaxel—head and neck cancer	0.0489	0.108	CbGbCtD
Vinblastine—TUBB2A—Docetaxel—head and neck cancer	0.0489	0.108	CbGbCtD
Vinblastine—TUBB6—Docetaxel—head and neck cancer	0.0489	0.108	CbGbCtD
Vinblastine—TUBB3—Docetaxel—head and neck cancer	0.0489	0.108	CbGbCtD
Vinblastine—TUBB4A—Docetaxel—head and neck cancer	0.0489	0.108	CbGbCtD
Vinblastine—TUBB8—Docetaxel—head and neck cancer	0.0489	0.108	CbGbCtD
Vinblastine—TUBB—Docetaxel—head and neck cancer	0.0409	0.0907	CbGbCtD
Vinblastine—TUBB1—Docetaxel—head and neck cancer	0.0409	0.0907	CbGbCtD
Vinblastine—TUBB4B—Docetaxel—head and neck cancer	0.0409	0.0907	CbGbCtD
Vinblastine—ABCC1—Docetaxel—head and neck cancer	0.0121	0.0267	CbGbCtD
Vinblastine—CYP2D6—Hydroxyurea—head and neck cancer	0.00941	0.0208	CbGbCtD
Vinblastine—ABCC2—Docetaxel—head and neck cancer	0.00894	0.0198	CbGbCtD
Vinblastine—TUBA1A—superior cervical ganglion—head and neck cancer	0.00511	0.121	CbGeAlD
Vinblastine—ABCB1—Docetaxel—head and neck cancer	0.00291	0.00645	CbGbCtD
Vinblastine—CYP3A4—Docetaxel—head and neck cancer	0.00175	0.00387	CbGbCtD
Vinblastine—Myelosuppression—Hydroxyurea—head and neck cancer	0.0014	0.0578	CcSEcCtD
Vinblastine—Myelosuppression—Fluorouracil—head and neck cancer	0.001	0.0416	CcSEcCtD
Vinblastine—TUBE1—parotid gland—head and neck cancer	0.00093	0.0221	CbGeAlD
Vinblastine—JUN—exocrine gland—head and neck cancer	0.000917	0.0218	CbGeAlD
Vinblastine—TUBE1—saliva-secreting gland—head and neck cancer	0.000891	0.0212	CbGeAlD
Vinblastine—TUBA1A—hair follicle—head and neck cancer	0.000882	0.021	CbGeAlD
Vinblastine—TUBG1—parotid gland—head and neck cancer	0.000832	0.0198	CbGeAlD
Vinblastine—TUBG1—saliva-secreting gland—head and neck cancer	0.000797	0.019	CbGeAlD
Vinblastine—Myelosuppression—Docetaxel—head and neck cancer	0.000725	0.03	CcSEcCtD
Vinblastine—TUBA1A—mouth—head and neck cancer	0.000692	0.0165	CbGeAlD
Vinblastine—TUBB—hair follicle—head and neck cancer	0.000689	0.0164	CbGeAlD
Vinblastine—TUBE1—trachea—head and neck cancer	0.000687	0.0163	CbGeAlD
Vinblastine—JUN—mouth—head and neck cancer	0.000685	0.0163	CbGeAlD
Vinblastine—Nystagmus—Fluorouracil—head and neck cancer	0.00066	0.0273	CcSEcCtD
Vinblastine—TUBG1—trachea—head and neck cancer	0.000615	0.0146	CbGeAlD
Vinblastine—TUBB3—connective tissue—head and neck cancer	0.000596	0.0142	CbGeAlD
Vinblastine—Neoplasm—Hydroxyurea—head and neck cancer	0.000592	0.0245	CcSEcCtD
Vinblastine—TUBA1A—neck—head and neck cancer	0.000592	0.0141	CbGeAlD
Vinblastine—TUBB4B—hair follicle—head and neck cancer	0.000588	0.014	CbGeAlD
Vinblastine—JUN—neck—head and neck cancer	0.000586	0.0139	CbGeAlD
Vinblastine—TUBD1—thyroid gland—head and neck cancer	0.00058	0.0138	CbGeAlD
Vinblastine—Numbness—Fluorouracil—head and neck cancer	0.000568	0.0235	CcSEcCtD
Vinblastine—Sensory loss—Fluorouracil—head and neck cancer	0.000544	0.0225	CcSEcCtD
Vinblastine—TUBE1—thyroid gland—head and neck cancer	0.000543	0.0129	CbGeAlD
Vinblastine—Extravasation—Fluorouracil—head and neck cancer	0.00054	0.0223	CcSEcCtD
Vinblastine—NR5A1—lymphoid tissue—head and neck cancer	0.000522	0.0124	CbGeAlD
Vinblastine—Cellulitis—Fluorouracil—head and neck cancer	0.000518	0.0214	CcSEcCtD
Vinblastine—TUBB8—head—head and neck cancer	0.000514	0.0122	CbGeAlD
Vinblastine—TUBD1—head—head and neck cancer	0.000514	0.0122	CbGeAlD
Vinblastine—ABCC6—connective tissue—head and neck cancer	0.000501	0.0119	CbGeAlD
Vinblastine—TUBG1—thyroid gland—head and neck cancer	0.000486	0.0116	CbGeAlD
Vinblastine—TUBE1—head—head and neck cancer	0.000482	0.0115	CbGeAlD
Vinblastine—TUBA1A—parotid gland—head and neck cancer	0.000482	0.0115	CbGeAlD
Vinblastine—Ileus—Docetaxel—head and neck cancer	0.00048	0.0199	CcSEcCtD
Vinblastine—JUN—parotid gland—head and neck cancer	0.000477	0.0114	CbGeAlD
Vinblastine—TUBA1A—saliva-secreting gland—head and neck cancer	0.000462	0.011	CbGeAlD
Vinblastine—JUN—saliva-secreting gland—head and neck cancer	0.000457	0.0109	CbGeAlD
Vinblastine—Neuritis—Docetaxel—head and neck cancer	0.000455	0.0188	CcSEcCtD
Vinblastine—Photophobia—Fluorouracil—head and neck cancer	0.000442	0.0183	CcSEcCtD
Vinblastine—TUBB3—lymphoid tissue—head and neck cancer	0.000435	0.0104	CbGeAlD
Vinblastine—TUBG1—head—head and neck cancer	0.000432	0.0103	CbGeAlD
Vinblastine—TUBA1A—connective tissue—head and neck cancer	0.000424	0.0101	CbGeAlD
Vinblastine—NR5A1—head—head and neck cancer	0.000421	0.01	CbGeAlD
Vinblastine—JUN—connective tissue—head and neck cancer	0.00042	0.00999	CbGeAlD
Vinblastine—ABCC1—hair follicle—head and neck cancer	0.000419	0.00996	CbGeAlD
Vinblastine—TUBA1A—epithelium—head and neck cancer	0.000403	0.00958	CbGeAlD
Vinblastine—JUN—epithelium—head and neck cancer	0.000399	0.00948	CbGeAlD
Vinblastine—TUBB2B—parotid gland—head and neck cancer	0.000398	0.00947	CbGeAlD
Vinblastine—Pancytopenia—Hydroxyurea—head and neck cancer	0.00039	0.0161	CcSEcCtD
Vinblastine—Extravasation—Docetaxel—head and neck cancer	0.00039	0.0161	CcSEcCtD
Vinblastine—TUBB2B—saliva-secreting gland—head and neck cancer	0.000381	0.00907	CbGeAlD
Vinblastine—TUBB—parotid gland—head and neck cancer	0.000377	0.00896	CbGeAlD
Vinblastine—TUBB2A—parotid gland—head and neck cancer	0.000375	0.00891	CbGeAlD
Vinblastine—TUBB6—parotid gland—head and neck cancer	0.00037	0.00879	CbGeAlD
Vinblastine—TUBB4A—connective tissue—head and neck cancer	0.000362	0.00862	CbGeAlD
Vinblastine—TUBB—saliva-secreting gland—head and neck cancer	0.000361	0.00858	CbGeAlD
Vinblastine—TUBD1—lymph node—head and neck cancer	0.00036	0.00856	CbGeAlD
Vinblastine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000359	0.0149	CcSEcCtD
Vinblastine—TUBB2A—saliva-secreting gland—head and neck cancer	0.000359	0.00854	CbGeAlD
Vinblastine—TUBA1A—trachea—head and neck cancer	0.000356	0.00847	CbGeAlD
Vinblastine—Bone pain—Docetaxel—head and neck cancer	0.000355	0.0147	CcSEcCtD
Vinblastine—TUBB6—saliva-secreting gland—head and neck cancer	0.000354	0.00842	CbGeAlD
Vinblastine—JUN—trachea—head and neck cancer	0.000353	0.00839	CbGeAlD
Vinblastine—TUBB3—head—head and neck cancer	0.000351	0.00835	CbGeAlD
Vinblastine—TUBB2B—connective tissue—head and neck cancer	0.00035	0.00833	CbGeAlD
Vinblastine—TUBB1—head—head and neck cancer	0.000343	0.00816	CbGeAlD
Vinblastine—TUBE1—lymph node—head and neck cancer	0.000338	0.00803	CbGeAlD
Vinblastine—ABCC6—thyroid gland—head and neck cancer	0.000333	0.00792	CbGeAlD
Vinblastine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00033	0.0137	CcSEcCtD
Vinblastine—TUBB2A—connective tissue—head and neck cancer	0.00033	0.00784	CbGeAlD
Vinblastine—Haemorrhage—Hydroxyurea—head and neck cancer	0.000329	0.0136	CcSEcCtD
Vinblastine—TUBB4B—parotid gland—head and neck cancer	0.000321	0.00764	CbGeAlD
Vinblastine—TUBA1A—lymphoid tissue—head and neck cancer	0.00031	0.00738	CbGeAlD
Vinblastine—TUBB6—epithelium—head and neck cancer	0.000309	0.00734	CbGeAlD
Vinblastine—TUBB4B—saliva-secreting gland—head and neck cancer	0.000308	0.00732	CbGeAlD
Vinblastine—Neoplasm—Docetaxel—head and neck cancer	0.000307	0.0127	CcSEcCtD
Vinblastine—JUN—lymphoid tissue—head and neck cancer	0.000307	0.0073	CbGeAlD
Vinblastine—TUBG1—lymph node—head and neck cancer	0.000302	0.00719	CbGeAlD
Vinblastine—ABCC6—head—head and neck cancer	0.000295	0.00703	CbGeAlD
Vinblastine—TUBB2B—trachea—head and neck cancer	0.000294	0.00699	CbGeAlD
Vinblastine—Alopecia—Hydroxyurea—head and neck cancer	0.00029	0.012	CcSEcCtD
Vinblastine—Angina pectoris—Fluorouracil—head and neck cancer	0.000288	0.0119	CcSEcCtD
Vinblastine—Phlebitis—Docetaxel—head and neck cancer	0.000287	0.0119	CcSEcCtD
Vinblastine—TUBB4B—connective tissue—head and neck cancer	0.000283	0.00672	CbGeAlD
Vinblastine—TUBA1A—thyroid gland—head and neck cancer	0.000282	0.0067	CbGeAlD
Vinblastine—Pancytopenia—Fluorouracil—head and neck cancer	0.000281	0.0116	CcSEcCtD
Vinblastine—JUN—thyroid gland—head and neck cancer	0.000279	0.00663	CbGeAlD
Vinblastine—TUBB—trachea—head and neck cancer	0.000278	0.00662	CbGeAlD
Vinblastine—TUBB2A—trachea—head and neck cancer	0.000277	0.00658	CbGeAlD
Vinblastine—Deafness—Docetaxel—head and neck cancer	0.000276	0.0114	CcSEcCtD
Vinblastine—TUBB6—trachea—head and neck cancer	0.000273	0.00649	CbGeAlD
Vinblastine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000265	0.011	CcSEcCtD
Vinblastine—TUBB4A—lymphoid tissue—head and neck cancer	0.000265	0.0063	CbGeAlD
Vinblastine—Anaemia—Hydroxyurea—head and neck cancer	0.000264	0.0109	CcSEcCtD
Vinblastine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00026	0.0108	CcSEcCtD
Vinblastine—Myocardial infarction—Fluorouracil—head and neck cancer	0.000258	0.0107	CcSEcCtD
Vinblastine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000258	0.0107	CcSEcCtD
Vinblastine—Malaise—Hydroxyurea—head and neck cancer	0.000258	0.0107	CcSEcCtD
Vinblastine—Leukopenia—Hydroxyurea—head and neck cancer	0.000256	0.0106	CcSEcCtD
Vinblastine—TUBA1A—head—head and neck cancer	0.00025	0.00594	CbGeAlD
Vinblastine—Convulsion—Hydroxyurea—head and neck cancer	0.000248	0.0103	CcSEcCtD
Vinblastine—JUN—head—head and neck cancer	0.000247	0.00589	CbGeAlD
Vinblastine—Agranulocytosis—Fluorouracil—head and neck cancer	0.000246	0.0102	CcSEcCtD
Vinblastine—Discomfort—Hydroxyurea—head and neck cancer	0.000241	0.00996	CcSEcCtD
Vinblastine—TUBB4A—thyroid gland—head and neck cancer	0.000241	0.00572	CbGeAlD
Vinblastine—Haemoglobin—Fluorouracil—head and neck cancer	0.000238	0.00984	CcSEcCtD
Vinblastine—TUBB6—lymphoid tissue—head and neck cancer	0.000238	0.00566	CbGeAlD
Vinblastine—TUBB4B—trachea—head and neck cancer	0.000237	0.00564	CbGeAlD
Vinblastine—Haemorrhage—Fluorouracil—head and neck cancer	0.000237	0.00979	CcSEcCtD
Vinblastine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000235	0.00974	CcSEcCtD
Vinblastine—Pharyngitis—Fluorouracil—head and neck cancer	0.000235	0.00972	CcSEcCtD
Vinblastine—TUBB2B—thyroid gland—head and neck cancer	0.000233	0.00553	CbGeAlD
Vinblastine—ABCC1—parotid gland—head and neck cancer	0.000229	0.00544	CbGeAlD
Vinblastine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000229	0.00946	CcSEcCtD
Vinblastine—Anorexia—Hydroxyurea—head and neck cancer	0.000223	0.00921	CcSEcCtD
Vinblastine—TUBB—thyroid gland—head and neck cancer	0.00022	0.00524	CbGeAlD
Vinblastine—TUBB2A—thyroid gland—head and neck cancer	0.000219	0.00521	CbGeAlD
Vinblastine—TUBB6—thyroid gland—head and neck cancer	0.000216	0.00514	CbGeAlD
Vinblastine—TUBB4A—head—head and neck cancer	0.000214	0.00508	CbGeAlD
Vinblastine—Alopecia—Fluorouracil—head and neck cancer	0.000209	0.00865	CcSEcCtD
Vinblastine—Angina pectoris—Docetaxel—head and neck cancer	0.000208	0.0086	CcSEcCtD
Vinblastine—TUBB4B—lymphoid tissue—head and neck cancer	0.000207	0.00492	CbGeAlD
Vinblastine—TUBB2B—head—head and neck cancer	0.000206	0.00491	CbGeAlD
Vinblastine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000203	0.0084	CcSEcCtD
Vinblastine—Pancytopenia—Docetaxel—head and neck cancer	0.000203	0.00838	CcSEcCtD
Vinblastine—Pain—Hydroxyurea—head and neck cancer	0.0002	0.00826	CcSEcCtD
Vinblastine—Constipation—Hydroxyurea—head and neck cancer	0.0002	0.00826	CcSEcCtD
Vinblastine—TUBB2A—head—head and neck cancer	0.000194	0.00462	CbGeAlD
Vinblastine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000192	0.00796	CcSEcCtD
Vinblastine—TUBB6—head—head and neck cancer	0.000192	0.00456	CbGeAlD
Vinblastine—Anaemia—Fluorouracil—head and neck cancer	0.00019	0.00788	CcSEcCtD
Vinblastine—TUBB4B—thyroid gland—head and neck cancer	0.000188	0.00447	CbGeAlD
Vinblastine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000188	0.00776	CcSEcCtD
Vinblastine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000186	0.00772	CcSEcCtD
Vinblastine—Myocardial infarction—Docetaxel—head and neck cancer	0.000186	0.00772	CcSEcCtD
Vinblastine—Leukopenia—Fluorouracil—head and neck cancer	0.000184	0.00763	CcSEcCtD
Vinblastine—Convulsion—Fluorouracil—head and neck cancer	0.000178	0.00738	CcSEcCtD
Vinblastine—Agranulocytosis—Docetaxel—head and neck cancer	0.000178	0.00735	CcSEcCtD
Vinblastine—TUBA1A—lymph node—head and neck cancer	0.000175	0.00416	CbGeAlD
Vinblastine—JUN—lymph node—head and neck cancer	0.000173	0.00412	CbGeAlD
Vinblastine—Discomfort—Fluorouracil—head and neck cancer	0.000173	0.00717	CcSEcCtD
Vinblastine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000172	0.00712	CcSEcCtD
Vinblastine—Haemoglobin—Docetaxel—head and neck cancer	0.000172	0.0071	CcSEcCtD
Vinblastine—Haemorrhage—Docetaxel—head and neck cancer	0.000171	0.00707	CcSEcCtD
Vinblastine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00017	0.00703	CcSEcCtD
Vinblastine—Pharyngitis—Docetaxel—head and neck cancer	0.000169	0.00701	CcSEcCtD
Vinblastine—ABCC1—trachea—head and neck cancer	0.000169	0.00402	CbGeAlD
Vinblastine—Asthenia—Hydroxyurea—head and neck cancer	0.000168	0.00693	CcSEcCtD
Vinblastine—TUBB4B—head—head and neck cancer	0.000167	0.00396	CbGeAlD
Vinblastine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000165	0.00681	CcSEcCtD
Vinblastine—Anorexia—Fluorouracil—head and neck cancer	0.00016	0.00663	CcSEcCtD
Vinblastine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00016	0.00661	CcSEcCtD
Vinblastine—Dizziness—Hydroxyurea—head and neck cancer	0.000154	0.00639	CcSEcCtD
Vinblastine—Paraesthesia—Fluorouracil—head and neck cancer	0.000151	0.00625	CcSEcCtD
Vinblastine—Alopecia—Docetaxel—head and neck cancer	0.000151	0.00624	CcSEcCtD
Vinblastine—TUBB4A—lymph node—head and neck cancer	0.00015	0.00356	CbGeAlD
Vinblastine—Vomiting—Hydroxyurea—head and neck cancer	0.000148	0.00614	CcSEcCtD
Vinblastine—Headache—Hydroxyurea—head and neck cancer	0.000146	0.00605	CcSEcCtD
Vinblastine—Decreased appetite—Fluorouracil—head and neck cancer	0.000146	0.00605	CcSEcCtD
Vinblastine—TUBB2B—lymph node—head and neck cancer	0.000145	0.00344	CbGeAlD
Vinblastine—Pain—Fluorouracil—head and neck cancer	0.000144	0.00595	CcSEcCtD
Vinblastine—Nausea—Hydroxyurea—head and neck cancer	0.000139	0.00574	CcSEcCtD
Vinblastine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000139	0.00573	CcSEcCtD
Vinblastine—Anaemia—Docetaxel—head and neck cancer	0.000137	0.00569	CcSEcCtD
Vinblastine—TUBB—lymph node—head and neck cancer	0.000137	0.00325	CbGeAlD
Vinblastine—TUBB2A—lymph node—head and neck cancer	0.000136	0.00324	CbGeAlD
Vinblastine—TUBB6—lymph node—head and neck cancer	0.000134	0.00319	CbGeAlD
Vinblastine—ABCC1—thyroid gland—head and neck cancer	0.000134	0.00318	CbGeAlD
Vinblastine—Leukopenia—Docetaxel—head and neck cancer	0.000133	0.00551	CcSEcCtD
Vinblastine—Convulsion—Docetaxel—head and neck cancer	0.000129	0.00533	CcSEcCtD
Vinblastine—Hypertension—Docetaxel—head and neck cancer	0.000128	0.00531	CcSEcCtD
Vinblastine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000124	0.00512	CcSEcCtD
Vinblastine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000119	0.00492	CcSEcCtD
Vinblastine—TUBB4B—lymph node—head and neck cancer	0.000117	0.00277	CbGeAlD
Vinblastine—Anorexia—Docetaxel—head and neck cancer	0.000116	0.00479	CcSEcCtD
Vinblastine—Diarrhoea—Fluorouracil—head and neck cancer	0.000115	0.00476	CcSEcCtD
Vinblastine—Dizziness—Fluorouracil—head and neck cancer	0.000111	0.0046	CcSEcCtD
Vinblastine—Paraesthesia—Docetaxel—head and neck cancer	0.000109	0.00451	CcSEcCtD
Vinblastine—Vomiting—Fluorouracil—head and neck cancer	0.000107	0.00442	CcSEcCtD
Vinblastine—Decreased appetite—Docetaxel—head and neck cancer	0.000105	0.00436	CcSEcCtD
Vinblastine—Headache—Fluorouracil—head and neck cancer	0.000105	0.00436	CcSEcCtD
Vinblastine—Pain—Docetaxel—head and neck cancer	0.000104	0.00429	CcSEcCtD
Vinblastine—Constipation—Docetaxel—head and neck cancer	0.000104	0.00429	CcSEcCtD
Vinblastine—Feeling abnormal—Docetaxel—head and neck cancer	0.0001	0.00414	CcSEcCtD
Vinblastine—Nausea—Fluorouracil—head and neck cancer	9.98e-05	0.00413	CcSEcCtD
Vinblastine—Gastrointestinal pain—Docetaxel—head and neck cancer	9.92e-05	0.00411	CcSEcCtD
Vinblastine—Abdominal pain—Docetaxel—head and neck cancer	9.59e-05	0.00397	CcSEcCtD
Vinblastine—ABCC2—lymph node—head and neck cancer	9.43e-05	0.00224	CbGeAlD
Vinblastine—Hypersensitivity—Docetaxel—head and neck cancer	8.94e-05	0.0037	CcSEcCtD
Vinblastine—Asthenia—Docetaxel—head and neck cancer	8.7e-05	0.0036	CcSEcCtD
Vinblastine—ABCC1—lymph node—head and neck cancer	8.31e-05	0.00198	CbGeAlD
Vinblastine—Diarrhoea—Docetaxel—head and neck cancer	8.3e-05	0.00343	CcSEcCtD
Vinblastine—Dizziness—Docetaxel—head and neck cancer	8.02e-05	0.00332	CcSEcCtD
Vinblastine—ABCB1—epithelium—head and neck cancer	7.81e-05	0.00186	CbGeAlD
Vinblastine—Vomiting—Docetaxel—head and neck cancer	7.71e-05	0.00319	CcSEcCtD
Vinblastine—Headache—Docetaxel—head and neck cancer	7.6e-05	0.00314	CcSEcCtD
Vinblastine—Nausea—Docetaxel—head and neck cancer	7.21e-05	0.00298	CcSEcCtD
Vinblastine—ABCB1—trachea—head and neck cancer	6.9e-05	0.00164	CbGeAlD
Vinblastine—CYP2D6—head—head and neck cancer	6.73e-05	0.0016	CbGeAlD
Vinblastine—ABCB1—lymphoid tissue—head and neck cancer	6.01e-05	0.00143	CbGeAlD
Vinblastine—ABCB1—thyroid gland—head and neck cancer	5.46e-05	0.0013	CbGeAlD
Vinblastine—ABCB1—head—head and neck cancer	4.84e-05	0.00115	CbGeAlD
Vinblastine—ABCB1—lymph node—head and neck cancer	3.39e-05	0.000807	CbGeAlD
Vinblastine—JUN—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	2.59e-05	0.000535	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	2.59e-05	0.000535	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—CCND1—head and neck cancer	2.53e-05	0.000524	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—PTEN—head and neck cancer	2.53e-05	0.000524	CbGpPWpGaD
Vinblastine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	2.52e-05	0.000521	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—AKT1—head and neck cancer	2.51e-05	0.000519	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—MAPK3—head and neck cancer	2.5e-05	0.000517	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—MAPK1—head and neck cancer	2.47e-05	0.000511	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—HRAS—head and neck cancer	2.46e-05	0.000508	CbGpPWpGaD
Vinblastine—JUN—Immune System—STAT6—head and neck cancer	2.46e-05	0.000508	CbGpPWpGaD
Vinblastine—JUN—ErbB1 downstream signaling—AKT1—head and neck cancer	2.45e-05	0.000507	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—MAPK1—head and neck cancer	2.45e-05	0.000506	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—EGFR—head and neck cancer	2.44e-05	0.000506	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—TP53—head and neck cancer	2.42e-05	0.0005	CbGpPWpGaD
Vinblastine—JUN—PDGFR-beta signaling pathway—HRAS—head and neck cancer	2.42e-05	0.0005	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—STAT3—head and neck cancer	2.41e-05	0.000498	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—PIK3CA—head and neck cancer	2.4e-05	0.000496	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—MAPK3—head and neck cancer	2.39e-05	0.000495	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—VEGFA—head and neck cancer	2.39e-05	0.000495	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.38e-05	0.000493	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—AKT1—head and neck cancer	2.38e-05	0.000492	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—MAPK1—head and neck cancer	2.38e-05	0.000491	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—EGFR—head and neck cancer	2.37e-05	0.000491	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.36e-05	0.000488	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.33e-05	0.000483	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.33e-05	0.000483	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—TP53—head and neck cancer	2.31e-05	0.000477	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—MAPK3—head and neck cancer	2.3e-05	0.000476	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—MAPK1—head and neck cancer	2.28e-05	0.000471	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—EGFR—head and neck cancer	2.28e-05	0.000471	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—CCND1—head and neck cancer	2.26e-05	0.000467	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.25e-05	0.000466	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL2—head and neck cancer	2.23e-05	0.000462	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.22e-05	0.00046	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—NAT2—head and neck cancer	2.22e-05	0.000459	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—MAPK1—head and neck cancer	2.19e-05	0.000453	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	2.19e-05	0.000453	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—TP53—head and neck cancer	2.17e-05	0.000449	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—AKT1—head and neck cancer	2.17e-05	0.000449	CbGpPWpGaD
Vinblastine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	2.16e-05	0.000447	CbGpPWpGaD
Vinblastine—JUN—BDNF signaling pathway—HRAS—head and neck cancer	2.16e-05	0.000446	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—MAPK1—head and neck cancer	2.15e-05	0.000445	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—EGFR—head and neck cancer	2.15e-05	0.000445	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.14e-05	0.000444	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—PIK3CA—head and neck cancer	2.14e-05	0.000443	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.14e-05	0.000443	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	2.14e-05	0.000443	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	2.13e-05	0.000441	CbGpPWpGaD
Vinblastine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	2.13e-05	0.000441	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—MAPK3—head and neck cancer	2.09e-05	0.000432	CbGpPWpGaD
Vinblastine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	2.05e-05	0.000423	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—AKT1—head and neck cancer	2.04e-05	0.000423	CbGpPWpGaD
Vinblastine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	2.02e-05	0.000418	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—CCND1—head and neck cancer	2.02e-05	0.000417	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TP53—head and neck cancer	1.99e-05	0.000413	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—MAPK1—head and neck cancer	1.99e-05	0.000411	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KISS1—head and neck cancer	1.99e-05	0.000411	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—HRAS—head and neck cancer	1.98e-05	0.00041	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—PIK3CA—head and neck cancer	1.98e-05	0.000409	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—HRAS—head and neck cancer	1.96e-05	0.000406	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	1.96e-05	0.000405	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—DPYD—head and neck cancer	1.95e-05	0.000403	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—UROD—head and neck cancer	1.91e-05	0.000395	CbGpPWpGaD
Vinblastine—JUN—BDNF signaling pathway—AKT1—head and neck cancer	1.9e-05	0.000394	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	1.9e-05	0.000392	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—BCL2L1—head and neck cancer	1.87e-05	0.000388	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.87e-05	0.000387	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—PIK3CA—head and neck cancer	1.87e-05	0.000387	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.86e-05	0.000385	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.86e-05	0.000385	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—YAP1—head and neck cancer	1.85e-05	0.000382	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—VEGFA—head and neck cancer	1.84e-05	0.00038	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—TP53—head and neck cancer	1.84e-05	0.00038	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	1.83e-05	0.000379	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—HRAS—head and neck cancer	1.83e-05	0.000378	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—STAT3—head and neck cancer	1.82e-05	0.000377	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—UROD—head and neck cancer	1.8e-05	0.000372	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.8e-05	0.000372	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.77e-05	0.000366	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.77e-05	0.000366	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.75e-05	0.000363	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—AKT1—head and neck cancer	1.75e-05	0.000362	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—MAPK3—head and neck cancer	1.74e-05	0.00036	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—AKT1—head and neck cancer	1.73e-05	0.000359	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—HRAS—head and neck cancer	1.73e-05	0.000358	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—TP53—head and neck cancer	1.73e-05	0.000357	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.71e-05	0.000354	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—AKT1—head and neck cancer	1.68e-05	0.000348	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—CCND1—head and neck cancer	1.67e-05	0.000346	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—TP53—head and neck cancer	1.67e-05	0.000345	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—NAT2—head and neck cancer	1.67e-05	0.000345	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—MAPK3—head and neck cancer	1.66e-05	0.000344	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—MAPK1—head and neck cancer	1.65e-05	0.000342	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—MAPK3—head and neck cancer	1.64e-05	0.00034	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—GRP—head and neck cancer	1.64e-05	0.000338	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	1.61e-05	0.000334	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STAT6—head and neck cancer	1.59e-05	0.000328	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—MAPK1—head and neck cancer	1.58e-05	0.000327	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.54e-05	0.000319	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CASP8—head and neck cancer	1.53e-05	0.000317	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—CCND1—head and neck cancer	1.53e-05	0.000316	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—AKT1—head and neck cancer	1.53e-05	0.000316	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.52e-05	0.000314	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	1.49e-05	0.000307	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.47e-05	0.000303	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—DPYD—head and neck cancer	1.46e-05	0.000303	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.46e-05	0.000301	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NAT2—head and neck cancer	1.45e-05	0.0003	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.41e-05	0.000292	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.41e-05	0.000292	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—YAP1—head and neck cancer	1.4e-05	0.000291	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	1.4e-05	0.000289	CbGpPWpGaD
Vinblastine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.39e-05	0.000288	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—TP53—head and neck cancer	1.39e-05	0.000287	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.39e-05	0.000287	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—YAP1—head and neck cancer	1.39e-05	0.000287	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—MAPK3—head and neck cancer	1.38e-05	0.000285	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.34e-05	0.000278	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.34e-05	0.000277	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—TP53—head and neck cancer	1.33e-05	0.000275	CbGpPWpGaD
Vinblastine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.32e-05	0.000273	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—BCL2—head and neck cancer	1.31e-05	0.000272	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—MAPK1—head and neck cancer	1.31e-05	0.000271	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—DPYD—head and neck cancer	1.27e-05	0.000263	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MAPK3—head and neck cancer	1.26e-05	0.000261	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.25e-05	0.000259	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.21e-05	0.00025	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—YAP1—head and neck cancer	1.21e-05	0.00025	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MAPK1—head and neck cancer	1.2e-05	0.000248	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—HRAS—head and neck cancer	1.19e-05	0.000247	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.19e-05	0.000246	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—UROD—head and neck cancer	1.18e-05	0.000244	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—MAPK1—head and neck cancer	1.14e-05	0.000236	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—AKT1—head and neck cancer	1.11e-05	0.00023	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—TYMS—head and neck cancer	1.11e-05	0.000229	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—TP53—head and neck cancer	1.1e-05	0.000228	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—GSTM1—head and neck cancer	1.1e-05	0.000227	CbGpPWpGaD
Vinblastine—JUN—Immune System—BCL2L1—head and neck cancer	1.09e-05	0.000226	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PTEN—head and neck cancer	1.09e-05	0.000225	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.07e-05	0.000222	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—GPX1—head and neck cancer	1.05e-05	0.000217	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.04e-05	0.000216	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CYP1A1—head and neck cancer	1.04e-05	0.000215	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.04e-05	0.000214	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TP53—head and neck cancer	1.01e-05	0.000208	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	9.36e-06	0.000194	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MAPK3—head and neck cancer	9.3e-06	0.000192	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—HRAS—head and neck cancer	9.14e-06	0.000189	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.09e-06	0.000188	CbGpPWpGaD
Vinblastine—JUN—Immune System—CASP8—head and neck cancer	8.92e-06	0.000185	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MAPK1—head and neck cancer	8.85e-06	0.000183	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—EGFR—head and neck cancer	8.85e-06	0.000183	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	8.85e-06	0.000183	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDH1—head and neck cancer	8.81e-06	0.000182	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.54e-06	0.000177	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	8.42e-06	0.000174	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	8.42e-06	0.000174	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—TYMS—head and neck cancer	8.33e-06	0.000172	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GSTM1—head and neck cancer	8.23e-06	0.00017	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NAT2—head and neck cancer	7.93e-06	0.000164	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GPX1—head and neck cancer	7.89e-06	0.000163	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CYP1A1—head and neck cancer	7.81e-06	0.000162	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PIK3CA—head and neck cancer	7.68e-06	0.000159	CbGpPWpGaD
Vinblastine—JUN—Immune System—BCL2—head and neck cancer	7.65e-06	0.000158	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NAT2—head and neck cancer	7.47e-06	0.000155	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NOTCH1—head and neck cancer	7.47e-06	0.000154	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	7.31e-06	0.000151	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—TYMS—head and neck cancer	7.25e-06	0.00015	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTM1—head and neck cancer	7.17e-06	0.000148	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HRAS—head and neck cancer	7.11e-06	0.000147	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	7.07e-06	0.000146	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—DPYD—head and neck cancer	6.96e-06	0.000144	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GPX1—head and neck cancer	6.87e-06	0.000142	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CYP1A1—head and neck cancer	6.8e-06	0.000141	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL2—head and neck cancer	6.74e-06	0.000139	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—YAP1—head and neck cancer	6.6e-06	0.000137	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—DPYD—head and neck cancer	6.55e-06	0.000136	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.41e-06	0.000133	CbGpPWpGaD
Vinblastine—JUN—Immune System—PTEN—head and neck cancer	6.34e-06	0.000131	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NOTCH1—head and neck cancer	6.33e-06	0.000131	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—AKT1—head and neck cancer	6.27e-06	0.00013	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—YAP1—head and neck cancer	6.22e-06	0.000129	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTGS2—head and neck cancer	6.18e-06	0.000128	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.97e-06	0.000124	CbGpPWpGaD
Vinblastine—JUN—Immune System—STAT3—head and neck cancer	5.67e-06	0.000117	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTGS2—head and neck cancer	5.54e-06	0.000115	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK3—head and neck cancer	5.42e-06	0.000112	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTEN—head and neck cancer	5.39e-06	0.000112	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK1—head and neck cancer	5.16e-06	0.000107	CbGpPWpGaD
Vinblastine—JUN—Immune System—EGFR—head and neck cancer	5.15e-06	0.000107	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NAT2—head and neck cancer	4.89e-06	0.000101	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTEN—head and neck cancer	4.83e-06	0.0001	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS2—head and neck cancer	4.64e-06	9.61e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CA—head and neck cancer	4.47e-06	9.26e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL2—head and neck cancer	4.36e-06	9.02e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—STAT3—head and neck cancer	4.32e-06	8.95e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—DPYD—head and neck cancer	4.29e-06	8.87e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCND1—head and neck cancer	4.25e-06	8.79e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—HRAS—head and neck cancer	4.14e-06	8.56e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAPK3—head and neck cancer	4.13e-06	8.55e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTEN—head and neck cancer	4.1e-06	8.48e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—YAP1—head and neck cancer	4.07e-06	8.41e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTEN—head and neck cancer	4.05e-06	8.38e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS2—head and neck cancer	4.04e-06	8.37e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—TYMS—head and neck cancer	3.96e-06	8.2e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAPK1—head and neck cancer	3.93e-06	8.13e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EGFR—head and neck cancer	3.93e-06	8.13e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTM1—head and neck cancer	3.92e-06	8.11e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CA—head and neck cancer	3.8e-06	7.87e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GPX1—head and neck cancer	3.75e-06	7.76e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—TYMS—head and neck cancer	3.73e-06	7.73e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP1A1—head and neck cancer	3.71e-06	7.68e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—head and neck cancer	3.7e-06	7.66e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.69e-06	7.64e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STAT3—head and neck cancer	3.67e-06	7.59e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—AKT1—head and neck cancer	3.65e-06	7.56e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GPX1—head and neck cancer	3.54e-06	7.32e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTEN—head and neck cancer	3.53e-06	7.3e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK3—head and neck cancer	3.5e-06	7.25e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.5e-06	7.24e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CA—head and neck cancer	3.41e-06	7.06e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK1—head and neck cancer	3.33e-06	6.9e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EGFR—head and neck cancer	3.33e-06	6.9e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HRAS—head and neck cancer	3.16e-06	6.53e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AKT1—head and neck cancer	3.11e-06	6.43e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CA—head and neck cancer	2.89e-06	5.98e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CA—head and neck cancer	2.86e-06	5.91e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—head and neck cancer	2.8e-06	5.79e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—AKT1—head and neck cancer	2.79e-06	5.77e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HRAS—head and neck cancer	2.68e-06	5.54e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CA—head and neck cancer	2.49e-06	5.15e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TYMS—head and neck cancer	2.44e-06	5.05e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.41e-06	4.99e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AKT1—head and neck cancer	2.36e-06	4.89e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AKT1—head and neck cancer	2.33e-06	4.83e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GPX1—head and neck cancer	2.31e-06	4.78e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.29e-06	4.73e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS2—head and neck cancer	2.21e-06	4.57e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.08e-06	4.31e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AKT1—head and neck cancer	2.03e-06	4.2e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTEN—head and neck cancer	1.93e-06	3.99e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.82e-06	3.76e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.36e-06	2.82e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.36e-06	2.81e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.28e-06	2.65e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTEN—head and neck cancer	1.19e-06	2.46e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AKT1—head and neck cancer	1.11e-06	2.3e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AKT1—head and neck cancer	1.05e-06	2.16e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.37e-07	1.73e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AKT1—head and neck cancer	6.84e-07	1.42e-05	CbGpPWpGaD
